NEFL and Alzheimer disease: For instance, neurofilament light chain (NfL) has emerged as a robust biomarker of neurodegeneration, providing valuable insights into disease progression in Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).